Adenoviral vectors have been widely used as vaccine candidates or potential vaccine candidates against infectious diseases due to the convenience of genome manipulation, their ability to accommodate large exogenous gene fragments, easy access of obtaining high-titer of virus, and high efficiency of transduction. At the same time, adenoviral vectors have also been used extensively in clinical research for cancer gene therapy and treatment of diseases caused by a single gene defect. However, application of adenovirus also faces a series of challenges such as poor targeting, strong immune response against the vector itself, and they cannot be used repeatedly. It is believed that these problems will be solved gradually with further research and technological development in related fields. Here, we review the construction methods of adenoviral vectors, including "gutless" adenovirus and discuss application of adenoviral vectors as prophylactic vaccines for infectious pathogens and their application prospects as therapeutic vaccines for cancer and other kinds of chronic infectious disease such as human papillomavirus, hepatitis B virus, and hepatitis C virus.
Keyphrases
- gene therapy
- infectious diseases
- hepatitis b virus
- hepatitis c virus
- immune response
- high efficiency
- papillary thyroid
- genome wide
- copy number
- mental health
- squamous cell
- squamous cell carcinoma
- multidrug resistant
- dendritic cells
- young adults
- lymph node metastasis
- transcription factor
- antimicrobial resistance
- liver failure
- childhood cancer
- drug delivery